Search results
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 4 days agoThis precipitous decline came after a period of immense operating success for the company. PFE...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 3 days agovaccine didn't enter the market until after the inoculations developed by Moderna and Pfizer had already taken dominant market shares. This meant it...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 3 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 5 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
What to know about the new 'FLiRT' COVID variants
Fox News· 1 day ago"FLiRT" is an acronym for the locations of the mutations the variants share on the virus' spike protein. CDC data suggests COVID-related hospitalizations...
Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years
Benzinga via Yahoo Finance· 22 hours agoWarren Buffett, the most successful dividend investor of all time, owes his success to a simple yet...
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 3 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines on its website, as one ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in...
